title: Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms.
abstract: Hepatocellular carcinoma (HCC), one of the most prevalent and lethal cancers, has shown an alarming rise in the USA. Without effective therapy for HCC, novel chemopreventive strategies may effectively circumvent the current morbidity and mortality. Oxidative stress predisposes to hepatocarcinogenesis and is the major driving force of HCC. Pomegranate, an ancient fruit, is gaining tremendous attention due to its powerful antioxidant properties. Here, we examined mechanism-based chemopreventive potential of a pomegranate emulsion (PE) against dietary carcinogen diethylnitrosamine (DENA)-induced rat hepatocarcinogenesis that mimics human HCC. PE treatment (1 or 10 g/kg), started 4 weeks prior to the DENA challenge and continued for 18 weeks thereafter, showed striking chemopreventive activity demonstrated by reduced incidence, number, multiplicity, size and volume of hepatic nodules, precursors of HCC. Both doses of PE significantly attenuated the number and area of γ-glutamyl transpeptidase-positive hepatic foci compared with the DENA control. PE also attenuated DENA-induced hepatic lipid peroxidation and protein oxidation. Mechanistic studies revealed that PE elevated gene expression of an array of hepatic antioxidant and carcinogen detoxifying enzymes in DENA-exposed animals. PE elevated protein and messenger RNA expression of the hepatic nuclear factor E2-related factor 2 (Nrf2). Our results provide substantial evidence, for the first time, that pomegranate constituents afford chemoprevention of hepatocarcinogenesis possibly through potent antioxidant activity achieved by upregulation of several housekeeping genes under the control of Nrf2 without toxicity. The outcome of this study strongly supports the development of pomegranate-derived products in the prevention and treatment of human HCC, which remains a devastating disease.
authors.affiliation: Cancer Therapeutics and Chemoprevention Group, Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, OH 44272, USA. abishayee@neoucom.edu
authors.forename: Anupam
authors.initials: A
authors.lastname: Bishayee
authors.forename: Deepak
authors.initials: D
authors.lastname: Bhatia
authors.forename: Roslin J
authors.initials: RJ
authors.lastname: Thoppil
authors.forename: Altaf S
authors.initials: AS
authors.lastname: Darvesh
authors.forename: Eviatar
authors.initials: E
authors.lastname: Nevo
authors.forename: Ephraim P
authors.initials: EP
authors.lastname: Lansky
mesh_terms: D000818:Animals; D008297:Male; D051381:Rats; D000477:Alkylating Agents / Q000633:toxicity; D000975:Antioxidants / Q000627:therapeutic use; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism; D004052:Diethylnitrosamine / Q000633:toxicity; D005723:gamma-Glutamyltransferase / Q000378:metabolism; D007124:Immunoenzyme Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism; D029561:Lythraceae / Q000737:chemistry; D018384:Oxidative Stress; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D017207:Rats, Sprague-Dawley; D051267:NF-E2-Related Factor 2 / Q000378:metabolism
chemical_list: D000477:Alkylating Agents; D000975:Antioxidants; D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase; D010936:Plant Extracts; D051267:NF-E2-Related Factor 2